{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:57:37Z","timestamp":1781798257457,"version":"3.54.5"},"reference-count":5,"publisher":"American Diabetes Association","issue":"3","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,1]]},"DOI":"10.2337\/dc25-1426","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T20:02:53Z","timestamp":1771617773000},"page":"e68-e68","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":0,"title":["Comment on Sun et al. SGLT2i Versus Metformin for Delirium Prevention in Type 2 Diabetes: A Real-World, Head-to-Head Comparative Study. Diabetes Care 2025;48:1361\u20131369"],"prefix":"10.2337","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8685-3925","authenticated-orcid":false,"given":"Cheng-Hsien","family":"Hung","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Chang Bing Show Chwan Memorial Hospital 1 , Changhua, Taiwan"},{"name":"Institute of Medicine, Chung Shan Medical University, Taichung 2 , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0701-5309","authenticated-orcid":false,"given":"Chun-Ting","family":"Lin","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Chung Shan Medical University, Taichung 2 , Taiwan"},{"name":"Department of Pharmacy, Chung Shan Medical University Hospital 3 , Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1235-0679","authenticated-orcid":false,"given":"James Cheng-Chung","family":"Wei","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Chung Shan Medical University, Taichung 2 , Taiwan"},{"name":"Department of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital 4 , Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"2026061811411470700_B1","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2337\/dc25-0433","article-title":"SGLT2i versus metformin for delirium prevention in type 2 diabetes: a real-world, head-to-head comparative study","volume":"48","author":"Sun","year":"2025","journal-title":"Diabetes Care"},{"key":"2026061811411470700_B2","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1185\/03007995.2015.1069739","article-title":"Sodium glucose co-transporter inhibitors for the management of diabetes mellitus: an opinion paper from the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy","volume":"31","author":"Clements","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"2026061811411470700_B3","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.2337\/dc25-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: Standards of Care in Diabetes\u20142025","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"key":"2026061811411470700_B4","doi-asserted-by":"crossref","first-page":"112109","DOI":"10.1016\/j.diabres.2025.112109","article-title":"Impact of sodium-glucose cotransporter-2 inhibitors on ovarian cancer risk in patients with type 2 diabetes mellitus: a multi-institutional TriNetX study","volume":"222","author":"Hung","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"2026061811411470700_B5","doi-asserted-by":"crossref","first-page":"e2024984","DOI":"10.1001\/jamanetworkopen.2020.24984","article-title":"Changes in health services use among commercially insured US populations during the COVID-19 pandemic","volume":"3","author":"Whaley","year":"2020","journal-title":"JAMA Netw Open"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/3\/e68\/857358\/dc251426.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/3\/e68\/857358\/dc251426.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:41:20Z","timestamp":1781797280000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/49\/3\/e68\/164465\/Comment-on-Sun-et-al-SGLT2i-Versus-Metformin-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":5,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2,20]]},"published-print":{"date-parts":[[2026,3,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc25-1426","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]}}}